- Full text PDF available (1)
KRAS is an EGFR effector in the RAS/RAF/ERK cascade that is mutated in about 40% of metastatic colorectal cancer (mCRC). Activating mutations in codons 12 and 13 of the KRAS gene are the only established negative predictors of response to anti-EGFR therapy and patients whose tumors harbor such mutations are not candidates for therapy. However, 40 to 60% of… (More)
Subarachnoid hemorrhage in a patient with two giant fusiform aneurysms arising from the posterior cerebral artery was treated by clipping the P2 segment of the artery, proximal to the first aneurysm. This combination of aneurysms has not previously been reported.